Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050) ? .

Filiaciones

Gaspar N:

Department of Childhood and Adolescent Oncology, Gustave Roussy Cancer Campus, Villejuif, France

Campbell-Hewson Q:

The Great North Children's Hospital, Royal Victoria Infirmary, Newcastle Upon Tyne, UK

Gallego Melcon S:

Pediatric Oncology and Hematology Service, University Hospital Vall d'Hebron, Barcelona, Spain

Locatelli F:

Department of Pediatric Hematology and Oncology, Ospedale Pediatrico Bambino Gesù, University of Rome, Rome, Italy

Venkatramani R:

Department of Pediatrics, Texas Children's Cancer Center, Baylor College of Medicine, Houston, USA

Hecker-Nolting S:

Department of Pediatric Oncology, Hematology, Immunology, Klinikum Stuttgart - Olgahospital, Stuttgart, Germany

Gambart M:

Pediatric Hemato-Oncology Unit, CHU Toulouse - Hôpital des Enfants, URCP, Toulouse, France

Bautista F:

Paediatric Haematology-Oncology Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain

Thebaud E:

Pediatric Oncology-Hematology and Immunology Department, CHU Nantes - Hôpital Mère-Enfant, Nantes, France

Aerts I:

SIREDO Oncology Center, Institut Curie, PSL Research University, Paris, France

Morland B:

Department of Paediatric Hematology/Oncology, Birmingham Children's Hospital, Birmingham, UK

Rossig C:

Department of Pediatric Hematology and Oncology, University Children's Hospital Muenster, Muenster, Germany

Canete Nieto A:

Children's Oncology Unit, Pediatric Service, Hospital Universitario y Politecnico La Fe, Valencia, Spain

Longhi A:

Chemotherapy Service, Istituto Ortopedico Rizzoli IRCCS, Bologna, Italy

Lervat C:

Pediatric and AYA Oncology Unit, Centre Oscar Lambret Lille, Lille, France

Entz-Werle N:

Pediatric Onco-Hematology Unit, Chu Strasbourg-Hôpital Hautepierre, Strasbourg, France

Strauss SJ:

Clinical Research Facility, University College London Hospitals NHS Trust, London, UK

Marec-Berard P:

Institute of Pediatric Hematology and Oncology, Centre Léon Bérard, Lyon, France

Okpara CE:

Clinical Research, Oncology Business Group, Eisai Ltd., Hatfield, UK

He C:

Biostatistics, Oncology Business Group, Eisai Inc., Woodcliff Lake, USA

Dutta L:

Clinical Research, Oncology Business Group, Eisai Inc., Woodcliff Lake, USA

Casanova M:

Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy